| CTRI Number |
CTRI/2024/09/073311 [Registered on: 04/09/2024] Trial Registered Prospectively |
| Last Modified On: |
04/09/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Effect of bundle of interventions on atelectasis in elderly undergoing general anesthesia |
|
Scientific Title of Study
|
Comparison of a bundle of interventions with existing practices to reduce anesthesia induced atelectasis in elderly undergoing general anesthesia for non-cardiac surgeries – A double blind, randomized controlled trial. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Avinash R Naik |
| Designation |
Junior Resident |
| Affiliation |
AIIMS Bhubaneswar |
| Address |
Department of Anaesthesiology and Critical Care, AIIMS Bhubaneswar.
Khordha ORISSA 751019 India |
| Phone |
9738102507 |
| Fax |
|
| Email |
avinashnaik0502@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr P Bhaskar Rao |
| Designation |
Professor |
| Affiliation |
AIIMS Bhubaneswar |
| Address |
Department of Anaesthesiology and Critical Care, AIIMS Bhubaneswar.
Khordha ORISSA 751019 India |
| Phone |
8926251076 |
| Fax |
|
| Email |
anaes_bhaskar@aiimsbhubaneswar.edu.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Avinash R Naik |
| Designation |
Junior Resident |
| Affiliation |
AIIMS Bhubaneswar |
| Address |
Department of Anaesthesiology and Critical Care, AIIMS Bhubaneswar.
Khordha ORISSA 751019 India |
| Phone |
9738102507 |
| Fax |
|
| Email |
avinashnaik0502@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of Anaesthesiology and Critical Care, All India Institute of Medical Sciences Bhubaneswar, Sijua, Patrapada, Khordha, Orissa, PIN 751019, India |
|
|
Primary Sponsor
|
| Name |
AIIMS Bhubaneswar |
| Address |
Sijua, Patrapada, Bhubaneswar, Khordha, Odisha, 751019 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Avinash R Naik |
All India Institute of Medical Sciences Bhubaneswar |
Department of Anaesthesiology and Critical Care, Room number 154, 1st floor, Sijua, Patrapada, Bhubaneswar, Khordha, Orissa, PIN 751019, India Khordha ORISSA |
9738102507
avinashnaik0502@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, All India Institute of Medical Sciences Bhubaneswar |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Bundle Group |
Preoxygenation in a 25degree head-up position with an FiO2 of 50% on volume controlled ventilation with a tidal volume of 8 ml/kg and a PEEP of 5 cm H2O. Then patients will be induced with institutional standard practice of premedication. During the intraoperative period, FiO2 kept as low as possible to maintain a SpO2 more than or equal to 95%. Additionally, hourly recruitment manoeuvres will be performed (PEEP of 30 cmH2O for 30 seconds). For reversal, Sugammadex will be administered at a dosage of 2 mg/kg. |
| Comparator Agent |
Existing Practice Group |
Preoxygenation in supine position with variable FiO2 on manual mode ventilation. Then patient will be induced with institutional standard practice of premedication. During intraoperative period, FiO2 kept at 50% without recruitment manoeuvres. For reversal, Neostigmine at a dosage of 0.05 mg/kg + Glycopyrrolate at a dosage of 0.1 mg/kg will be administered. |
|
|
Inclusion Criteria
|
| Age From |
65.00 Year(s) |
| Age To |
90.00 Year(s) |
| Gender |
Both |
| Details |
Patients posted to surgeries under general anesthesia with duration of surgeries more than or equal to 2 hours belonging to ASA I - III including elective and emergency operations, as well as both laparoscopic and open surgical techniques. |
|
| ExclusionCriteria |
| Details |
Patient refusal to give consent, patients with BMI more than or equal to 30 kg/m2, with pre-existing lung disease / chest trauma, patients posted for cardiothoracic/lung surgeries, patient not getting extubated within 24 hours of surgery in ICU, Pregnant woman, patients with progressive neuromuscular weakness, chronically bed-ridden, patients posted for redo surgeries. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
To compare the incidence of anesthesia induced atelectasis in both groups after surgery using
lung aeration score of score more than or equal to 2 by lung ultrasonography |
Before induction of anesthesia and after 1 hour of surgery and within 24 hours if patient shifted to ICU intubated |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
To compare the incidence of anesthesia induced atelectasis in Laparoscopic & Open
surgeries |
Before induction of anesthesia and after 1 hour of surgery and within 24 hours if patient shifted to ICU intubated |
| To compare the incidence of postoperative pulmonary complications |
Seven days postoperatively or till the day of discharge |
To compare the effect of predefined causes for anesthesia induced atelectasis such as
age, PEEP, position of surgery, etc. |
Intraoperative |
|
|
Target Sample Size
|
Total Sample Size="130" Sample Size from India="130"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
15/09/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The incidence of anesthesia induced atelectasis was found to be 90% in patients undergoing general anesthesia. And anesthesia induced atelectasis accounts for nearly 30% for the development of postoperative pulmonary complications which have a major impact on the mortality and morbidity of patients undergoing major surgery. There have been studies for techniques to reduce the incidence of anesthesia induced atelectasis in isolation. So, we hypothesise that these interventions when combined together (bundle) will be more effective than existing institutional practices in reducing anesthesia induced atelectasis. |